Microfluidic immunoassays for point-of-care testing of SARS-CoV-2 antigens and antibodies
Cuili Li,
No information about this author
Wan Zhou,
No information about this author
Angel Gutierrez Ruiz
No information about this author
et al.
TrAC Trends in Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
177, P. 117809 - 117809
Published: June 6, 2024
Language: Английский
Recent advances in point-of-care testing (POCT) system based on upconversion luminescent materials
Materials Science and Engineering B,
Journal Year:
2025,
Volume and Issue:
314, P. 118049 - 118049
Published: Jan. 27, 2025
Language: Английский
Utilizing Nanomaterials in Microfluidic Devices for Disease Detection and Treatment
Nanomaterials,
Journal Year:
2025,
Volume and Issue:
15(6), P. 434 - 434
Published: March 12, 2025
Microfluidic
technology
has
gained
widespread
application
in
the
field
of
biomedical
research
due
to
its
exceptional
sensitivity
and
high
specificity.
Particularly
when
combined
with
nanomaterials,
synergy
between
two
significantly
advanced
fields
such
as
precision
medicine,
drug
delivery,
disease
detection,
treatment.
This
article
aims
provide
an
overview
latest
achievements
microfluidic
nanomaterials
detection
It
delves
into
applications
detecting
blood
parameters,
cardiovascular
markers,
neurological
tumor
markers.
Special
emphasis
is
placed
on
their
roles
treatment,
including
models
vessels,
blood–brain
barrier,
lung
chips,
tumors.
The
development
emerging
medical
technologies,
particularly
skin
interactive
devices
imaging,
also
introduced.
Additionally,
challenges
future
prospects
current
clinical
are
discussed.
In
summary,
play
indispensable
role
With
continuous
advancement
technology,
will
become
even
more
profound
extensive.
Language: Английский
Reimagining point-of-care assays: Automated digital microfluidics for multiplex in vitro diagnostics
Talanta,
Journal Year:
2025,
Volume and Issue:
294, P. 128270 - 128270
Published: May 3, 2025
Language: Английский
Aggregation-induced emission-based competitive immunoassays for “signal-on” detection of proteins with multifunctional metal–organic frameworks as signal tags
Fengli Gao,
No information about this author
Meiling Liu,
No information about this author
Weiqiang Wang
No information about this author
et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy,
Journal Year:
2024,
Volume and Issue:
325, P. 125088 - 125088
Published: Sept. 3, 2024
Language: Английский
Au@Pt@Pd nanozymes based lateral flow immunoassay for quantitative detection of SARS-CoV-2 nucleocapsid protein in nasal swab samples
Microchimica Acta,
Journal Year:
2024,
Volume and Issue:
191(12)
Published: Nov. 7, 2024
Language: Английский
Generation, Manipulation, Detection and Biomedical Applications of Magnetic Droplets in Microfluidic Chips
Chenyang Xu,
No information about this author
Huanhuan Shi,
No information about this author
Zhongjian Tan
No information about this author
et al.
The Analyst,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Microfluidic
systems
incorporating
magnetic
droplets
have
emerged
as
a
focal
point
of
significant
interest
within
the
biomedical
domain.
The
allure
these
lies
in
their
capacity
to
offer
precise
control,
enable
contactless
operation,
and
accommodate
minimal
sample
concentration
requirements.
Such
remarkable
features
serve
mitigate
errors
arising
from
human
operation
other
factors
during
cell
or
molecular
detection.
By
providing
innovative
solutions
for
diagnostics
immunoassay
applications,
droplet
microfluidics
enhance
accuracy
efficiency
procedures.
This
review
undertakes
comprehensive
examination
research
progress
microfluidic
centered
around
droplets.
It
adheres
sequential
presentation
approach,
commencing
fundamental
principles,
specifically
generation
on
chip,
proceeding
transmission
mixing
microchannel
Language: Английский
Novel microfluidic chips integrated with smart devices for in-situ detection of foodborne pathogenic bacteria
Ruibin Hu,
No information about this author
Wen Wang,
No information about this author
Qingfeng Zheng
No information about this author
et al.
Current Opinion in Food Science,
Journal Year:
2024,
Volume and Issue:
unknown, P. 101269 - 101269
Published: Dec. 1, 2024
Language: Английский
Discovery of Fluorescent Naturally‐Occurring Inhibitor of SARS‐CoV‐2 Main Protease by AIE Fluorescent Probe
ChemMedChem,
Journal Year:
2024,
Volume and Issue:
19(21)
Published: July 8, 2024
Abstract
Target‐based
high‐throughput
screening
(HTS)
is
an
efficient
way
to
identify
potent
drugs.
However,
the
accuracy
of
HTS
could
be
affected
by
Pan‐Assay
Interference
Compounds
(PAINS).
One
reason
for
generation
PAINS
that
inherent
photophysical
property
screened
compounds
interfere
with
typically
used
assay
signals
including
absorption
and
fluorescence.
Our
previous
studies
indicate
fluorescent
probe
based
on
fluorophore
characteristics
aggregation‐induced
emission
(AIE)
provide
high
HTS,
especially
natural
products.
Herein,
we
report
AIE‐based
main
protease
(M
pro
)
severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2).
We
designed
synthesized
AIE
ZLHG5,
which
has
a
site
can
specifically
cleaved
M
produce
light‐up
Thanks
large
Stokes
shift
(~200
nm),
effectively
inhibitors.
After
library
products
obtained
two
coumarin‐originated
inhibitory
activity
towards
protease.
This
study
provides
both
useful
inhibitors
Language: Английский
Embracing Poisson Encapsulation Statistics for Improved Droplet Digital Immunoassay
Yujuan Chai,
No information about this author
Xiaoxiang Hu,
No information about this author
Qi Fang
No information about this author
et al.
Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 18, 2024
Digital
immunoassays
enable
the
detection
of
protein
biomarkers
with
very
low
concentrations,
but
analysis
stringently
requires
single-bead
encapsulation.
Low
bead
density
has
been
adopted
to
minimize
multiple-bead
encapsulations,
trade-off
is
droplet
effectiveness
(∼10%)
in
droplet-based
assays.
Here
we
report
method
inclusive
digital
ELISA
(iddELISA)
that
embraces
all
types
encapsulations
by
factoring
their
varied
"on-off"
probabilities
statistical
inference.
We
derived
model,
optimized
encapsulation
and
immunoreaction,
developed
an
image
pipeline
for
accurate
recognition,
showing
approximately
40%
droplets
could
be
used
analysis.
Using
SARS-CoV-2
nucleocapsid
as
a
demonstration,
iddELISA
achieved
limit
0.71
fg/mL,
which
was
much
lower
than
conventional
well
ELISA.
By
effectively
incorporating
multiple
simplified
immunoassay
while
improving
counting
efficiency
sensitivity,
representing
unique
concept
immunoassays.
Language: Английский